Health diagnostics market on growth path

Glucose monitoring is the largest application in the market and is estimated to be worth nearly $7.8bn this year. US-based BCC expects this to increase at 5.1% per annum to reach nearly $10bn in 2014.

Blood chemistry and electrolyte, the second-largest segment, is expected to reach nearly $3.9bn in 2014, after increasing from the 2009 estimate of $2.2bn at an annual growth rate of 12%.

BCC expects cardiac markers to be the fastest-growing segment, and is projecting these to increase at 13.8% per annum from an estimated $619m in 2009 to nearly $1.2bn in 2014.

BCC said: “The wider availability of POC testing has revolutionized the continuum of the patient-care process by providing laboratory results rapidly and efficiently at these locations [outside hospitals]. The trend toward greater POC testing is driven by the faster diagnostic benefits it provides.”

POC products include handheld instruments, small analytical instruments, instruments with multi-test capabilities, diagnostic kits (such as dipsticks and cassette devices), and portable data systems to collect, manage, and process test data.

The BCC report covers major product segments, which, along with those already mentioned, are: cholesterol testing/monitoring, drug and alcohol screening, infectious disease detection and testing, pregnancy and fertility tests, hemoglobin/hemostasis testing/monitoring, tumor marker detection, and urine chemistry analyses.

[ Back ]